- Home
- App-Analyse
- PatienTrials
- PatienTrials Vs. VirTrial Participant
PatienTrials im Vergleich zu VirTrial Participant Nutzung und Statistiken
PatienTrials helps pharma companies and clinicians run global clinical trials virtually, more efficiently in a closed community setting over HIPAA & GDPR compliant collaboration platform. PatienTrials aims to improve patient adherence by empowering participants with information on the progress of treatment at their fingertips in a community setting, that promotes self-care. PatienTrials captures high-quality patient generated data through solutions based on instant messaging, HealthKit, AI and bots, is poised to make a positive impact on drug development. Monitored by proprietary AI agent for adverse events, PatienTrials reduces study risk and lowers development costs. Founded in 2016, PatienTrials is the first company to bring clinical trials on to a HIPAA & GDPR compliant instant messaging platform.
- Apple App Store
- Kostenlos
- Medizin
Rang speichern
- -
VirTrial provides convenient access to clinical trials for study participants around the world.
The VirTrial Patient application connects study participants to the research site staff for virtual telemedicine visits within a study protocol. The VirTrial app provides a virtual exam room for study participants to see the study staff and physician without the inconvenience of travel to the study site.
VirTrial complies with all local, national and global compliance and security requirements
- Apple App Store
- Kostenlos
- Medizin
Rang speichern
- -
PatienTrialsvs. VirTrial Participant Ranking-Vergleich
Vergleichen Sie PatienTrials den Ranking-Trend der letzten 28 Tage mit VirTrial Participant
Rang
Keine Daten verfügbar
PatienTrials im Vergleich zu VirTrial Participant Ranking im Ländervergleich
Vergleichen Sie PatienTrials den Ranking-Trend der letzten 28 Tage mit VirTrial Participant
Keine Daten zum Anzeigen
Stellen Sie mit unserer kostenlosen Testversion Vergleiche mit jeder Website an
PatienTrials VS.
VirTrial Participant
Dezember 15, 2024